Skip to content

Canadian ophthalmic company QLT Inc. plans to return $100M cash to shareholders

QLT Inc., (Nasdaq: QLTI; TSX: QLT), a public biotech company focused on the commercialization of innovative ophthalmic products has announced significant corporate and structural re-organisation, including the return of $100M in cash to its shareholders. Based in Vancouver, Canada the company has undergone significant re-structuring since an activist shareholder, NB Public Equity Komplementar ApS, gained control of the company.